Company Filing History:
Years Active: 2012
Title: Yo-ichi Ishida: Pioneer in Liver Disease Diagnosis
Introduction
Yo-ichi Ishida is a notable inventor based in Miyazaki, Japan. He has made significant contributions to the field of medical diagnostics, particularly focusing on liver diseases. His innovative work has led to the development of a biomarker that simplifies the diagnosis of liver conditions, enhancing medical examination processes.
Latest Patents
Ishida holds one patent titled "Biomarker for diagnosis of liver disease." This patent discloses a marker that aids in diagnosing liver diseases with ease. Furthermore, it involves an antibody directed against the marker, a diagnostic agent, and methods for diagnosis and marker detection in blood or serum. His proteome analysis demonstrated that the levels of full-length kininogen and specific partial peptides (sequence A: position 440 to 456, sequence B: position 439 to 456, and sequence C: position 438 to 456) in the sera of patients with non-alcoholic fatty liver disease vary significantly from those in healthy individuals. Ishida's invention not only enables identification of chronic hepatitis and asymptomatic virus carriers but also improves the convenience of medical examinations for non-alcoholic fatty liver disease through the use of kininogen-based and C4-based markers.
Career Highlights
Over his career, Ishida has worked with the Miyazaki Prefectural Industrial Support Foundation and Kagoshima University, where he furthered his research in medical diagnostics. His experience in these institutions has played a critical role in the development of his innovative technologies.
Collaborations
Ishida has collaborated with notable coworkers such as Hirohito Tsubouchi and Hirofumi Uto. These partnerships have contributed to the enhancement and validation of his research, driving forward innovations in liver disease diagnostics.
Conclusion
Yo-ichi Ishida stands out as a key inventor in the realm of medical research, particularly in liver disease diagnostics. His singular patent highlights the potential to transform the way liver diseases are diagnosed, which not only benefits healthcare professionals but also enhances patient care. As he continues his work, Ishida remains an influential figure in the ongoing quest for medical innovation.